The Team

The Team

The IPF-PRO/ILD-PRO Registry is led by a team of clinical and statistical respiratory faculty and outcomes operational staff at Duke Clinical Research Institute in collaboration with Boehringer Ingelheim Medical Affairs. A special recognition goes to the site investigators and clinical site staff across the country for their contributions to the Registry and their work on numerous related publications. This research is funded by Boehringer Ingelheim Pharmaceuticals, Inc.

Faculty

port_scott

Scott Palmer, MD, MHS
Principal Investigator

port_snyder

Laurie Snyder, MD, MHS
Co-Principal Investigator; Study Publications Lead

port_todd

Jamie Todd, MD, MHS
Co-Principal Investigator; Principal Investigator for the     IPF-PRO/ILD-PRO Biomarker Study

meagan2

Megan Neely, PhD
Co-Principal Investigator; Statistical Principal Investigator

durheim3

Michael Durheim, MD
Co-Investigator

port_aparna

Aparna Swaminathan, MD, MHS
Co-Investigator

Clinical Sites

IPF_expansion_map_13may2026
IPF_map_11may2026_ILD

For more information on the Registry or our research, please contact us at IPF-PRO@dm.duke.edu.